First known as REGN-COV2 and now as Casirivimab and Imdevimab, Regeneron’s monoclonal antibody cocktail authorized by the U.S. Food and Drug Administration (FDA) on an…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.